GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » Other Income (Expense)

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Other Income (Expense) : ¥-162 Mil (TTM As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co Other Income (Expense)?

Guizhou Bailing Group Pharmaceutical Co's other income expense for the Guizhou Bailing Group Pharmaceutical Co's pretax income for the three months ended in Jun. 2024 was ¥-28 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was ¥-162 Mil.

Guizhou Bailing Group Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Guizhou Bailing Group Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Bailing Group Pharmaceutical Co Other Income (Expense) Chart

Guizhou Bailing Group Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -107.10 -69.81 -59.49 -71.58 -150.19

Guizhou Bailing Group Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.05 33.15 -131.16 -35.47 -28.13

Guizhou Bailing Group Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-162 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guizhou Bailing Group Pharmaceutical Co  (SZSE:002424) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Guizhou Bailing Group Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » Other Income (Expense)
Comparable Companies
SZSE:002099 SHSE:603567 SZSE:300630 SZSE:002020 SZSE:002332 SZSE:000766 SZSE:002038 SHSE:600211 SHSE:600267 SHSE:600195 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000
Website
http://www.gzbl.com
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.
Executives
Jiang Wei Director
Jiang Yong Directors, executives
Chen Pei Directors, executives
Kuang Xun Hua Director
Niu Min Directors, Directors, and Executives
Chen Zhi Securities Affairs Representative
Zheng Rong Executives
Li Qiang Supervisors
Xia Wen Supervisors
Wang Xiao Dong Supervisors
Teng Chun Jie Supervisors
Li Hui Fang Supervisors
Zhang Jin Fen Director
Cai Shou Xian Executives

Guizhou Bailing Group Pharmaceutical Co Headlines

No Headlines